Objective To characterize patients with systemic lupus erythematosus (SLE) affected by
coronavirus disease 2019 (COVID‐19) and to analyze associations of comorbidities and …

Background Patients with systemic lupus erythematosus (SLE) are at risk of developing
COVID-19 due to underlying immune abnormalities and regular use of immunosuppressant …

Objective Hydroxychloroquine (HCQ) is a mainstay of therapy in the treatment of SLE. The
effect of HCQ on platelets and vascular health is uncertain. We investigated the relationship …

Background Complement activation has been associated with adverse pregnancy outcomes
(APO) in SLE. Pregnant women with SLE were studied to evaluate whether complement …

Objective This article assesses the application of the Royal College of Obstetricians and
Gynaecologists (RCOG) venous thromboembolism (VTE) risk model on a cohort of …

564 Vascular Medicine 26 (5) filling was 73.6%(IQR 68.5–78.0%). There was an inverse
correlation between measures of FMD and PBR (r=− 0.29 [95% CI− 0.02 to− 0.53], p= 0.034; …

Background: Vascular dysfunction is an important marker of cardiovascular risk. Sidestream
darkfield imaging is a noninvasive modality for assessing structural abnormalities of the …

Neighborhood Deprivation and Race/Ethnicity Affects COVID-19 Risk and Severity in SLE |
Arthritis & Rheumatology; 72:2, 2020. | Web of Science Conteúdo principal 1 Busca 2 Rodapé …